Technology
Health
Biotechnology

Aravive

$8.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.49 (6.37%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Aravive and other stocks, options, ETFs, and crypto commission-free!

About

Aravive, Inc. Common Stock, also called Aravive, is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Read More Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.

Employees
14
Headquarters
Houston, Texas
Founded
2008
Market Cap
86.64M
Price-Earnings Ratio
7.78
Dividend Yield
0.00
Average Volume
61.05K
High Today
$8.54
Low Today
$7.21
Open Price
$7.64
Volume
46.42K
52 Week High
$15.30
52 Week Low
$3.07

Collections

Technology
Health
Biotechnology
Cancer Prevention
Medical
2014 IPO
US
North America
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.